Recall of GALILEO ECHO INSTRUMENT

According to Health Canada (via FOI), this recall involved a device in Canada that was produced by DOMINION BIOLOGICALS LTD.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    22992
  • Event Risk Class
    II
  • Event Initiated Date
    2010-04-07
  • Event Country
  • Event Source
    HC
  • Notes / Alerts
    Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
  • Extra notes in the data
  • Reason
    This medical device recall is intended to address the following defects previously reported to health canada. these issues have been partially corrected with the release of echo software release 1.2 patch 2: - cc-09-042-02 important notification regarding echo antibody screen and id interpretations (health canada recall # 51956). - cc-10-01-001 investigation of sporadic no type determined (ntd) interpretations for hemagglutination assays on the echo (health canada recall #53353).

Device

  • Model / Serial
    Model Catalog: 00870000 (Lot serial: n/a)
  • Product Description
    Immucor Galileo Echo Blood Bank Analyzer
  • Manufacturer

Manufacturer

  • Manufacturer Address
    DARTMOUTH
  • Manufacturer Parent Company (2017)
  • Source
    HC